Search research articles
Contact Us
Filters
Showing results (1-10 of 157) with videos related to
Page
of 16
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
December 16, 2022
Stochastic Stomatitis: Radiation Recall Reactions in the Era of Immune Checkpoint Blockade
Melvin L K Chua
The Journal of Urology
|
January 13, 2019
Editorial Comment
Melvin L K Chua
International Journal of Radiation Oncology, Biology, Physics
|
May 4, 2019
Circulating Tumor DNA to Personalize Treatment in Nasopharynx Cancer - Time to Look "Ahead"?
Melvin L K Chua
Cancer Communications (London, England)
|
March 20, 2020
Surgery as an alternative to radiotherapy in early-stage nasopharyngeal carcinoma: innovation at the expense of uncertainty
Luo Huang, Melvin L K Chua
Nature Reviews. Clinical Oncology
|
December 16, 2018
Multidisciplinary team meetings - challenges of implementation science
N Gopalakrishna Iyer, Melvin L K Chua
Lancet (London, England)
|
August 28, 2016
Gemcitabine: a game changer in nasopharyngeal carcinoma
Melvin L K Chua, Anthony T C Chan
JAMA Oncology
|
October 16, 2025
Unexpected Results of Induction Chemotherapy vs Adjuvant Chemotherapy
Melvin L K Chua, Darren W T Lim
Annals of Translational Medicine
|
November 19, 2020
Discovering biomarkers of radioresistance in a radiosensitive cancer: a clinical paradox in nasopharyngeal carcinoma
Laura L Y Tan, Melvin L K Chua
JAMA Oncology
|
July 3, 2020
Risk of COVID-19 in Patients With Cancer-Reply
Melvin L K Chua, Jing Yu, Conghua Xie
BMC Medicine
|
November 29, 2023
Radiomics in precision oncology: hype or ludum mutante
Shi Hui Tay, Xin Zhang, Melvin L K Chua
Page
of 16
Search research articles
Search
Showing results (1-10 of 157) with videos related to
Sort By:
Page
of 16
International Journal of Radiation Oncology, Biology, Physics
|
December 16, 2022
Stochastic Stomatitis: Radiation Recall Reactions in the Era of Immune Checkpoint Blockade
Melvin L K Chua
The Journal of Urology
|
January 13, 2019
Editorial Comment
Melvin L K Chua
International Journal of Radiation Oncology, Biology, Physics
|
May 4, 2019
Circulating Tumor DNA to Personalize Treatment in Nasopharynx Cancer - Time to Look "Ahead"?
Melvin L K Chua
Cancer Communications (London, England)
|
March 20, 2020
Surgery as an alternative to radiotherapy in early-stage nasopharyngeal carcinoma: innovation at the expense of uncertainty
Luo Huang, Melvin L K Chua
Nature Reviews. Clinical Oncology
|
December 16, 2018
Multidisciplinary team meetings - challenges of implementation science
N Gopalakrishna Iyer, Melvin L K Chua
Lancet (London, England)
|
August 28, 2016
Gemcitabine: a game changer in nasopharyngeal carcinoma
Melvin L K Chua, Anthony T C Chan
JAMA Oncology
|
October 16, 2025
Unexpected Results of Induction Chemotherapy vs Adjuvant Chemotherapy
Melvin L K Chua, Darren W T Lim
Annals of Translational Medicine
|
November 19, 2020
Discovering biomarkers of radioresistance in a radiosensitive cancer: a clinical paradox in nasopharyngeal carcinoma
Laura L Y Tan, Melvin L K Chua
JAMA Oncology
|
July 3, 2020
Risk of COVID-19 in Patients With Cancer-Reply
Melvin L K Chua, Jing Yu, Conghua Xie
BMC Medicine
|
November 29, 2023
Radiomics in precision oncology: hype or ludum mutante
Shi Hui Tay, Xin Zhang, Melvin L K Chua
Page
of 16